IL-6/gp130 signaling in CD4 + T cells drives the pathogenesis of pulmonary hypertension
Proceedings of the National Academy of Sciences · 16.04.2024 · 121 (16)
DOI: 10.1073/pnas.2315123121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 11.04.2024. Verfasst von Tomohiko Ishibashi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka 564-8565, Japan. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Interleukin-6. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), MEXT | JST | Precursory Research for Embryonic Science and Technology (PRESTO).
Abstract (Originalsprache)
Pulmonary arterial hypertension (PAH) is characterized by stenosis and occlusions of small pulmonary arteries, leading to elevated pulmonary arterial pressure and right heart failure. Although accumulating evidence shows the importance of interleukin (IL)-6 in the pathogenesis of PAH, the target cells of IL-6 are poorly understood. Using mice harboring the floxed allele of gp130 , a subunit of the IL-6 receptor, we found substantial Cre recombination in all hematopoietic cell lineages from the primitive hematopoietic stem cell level in SM22α-Cre mice. We also revealed that a CD4 + cell-specific gp130 deletion ameliorated the phenotype of hypoxia-induced pulmonary hypertension in mice. Disruption of IL-6 signaling via deletion of gp130 in CD4 + T cells inhibited phosphorylation of signal transducer and activator of transcription 3 (STAT3) and suppressed the hypoxia-induced increase in T helper 17 cells. To further examine the role of IL-6/gp130 signaling in more severe PH models, we developed Il6 knockout (KO) rats using the CRISPR/Cas9 system and showed that IL-6 deficiency could improve the pathophysiology in hypoxia-, monocrotaline-, and Sugen5416/hypoxia (SuHx)-induced rat PH models. Phosphorylation of STAT3 in CD4 + cells was also observed around the vascular lesions in the lungs of the SuHx rat model, but not in Il6 KO rats. Blockade of IL-6 signaling had an additive effect on conventional PAH therapeutics, such as endothelin receptor antagonist (macitentan) and soluble guanylyl cyclase stimulator (BAY41-2272). These findings suggest that IL-6/gp130 signaling in CD4 + cells plays a critical role in the pathogenesis of PAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka 564-8565, Japan.
- Department of Pathology, National Cerebral and Cardiovascular Center, Suita, Osaka 564-8565, Japan.
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka 564-8565, Japan.
- Omics Research Center, National Cerebral and Cardiovascular Center, Suita, Osaka 564-8565, Japan.
- Department of Anatomy, Keio University School of Medicine, Tokyo 160-8582, Japan.
- Department of Immune Regulation, Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan.
ORCID-Profile: Tomohiko Ishibashi, Tadakatsu Inagaki, Makoto Okazawa, Ryotaro Asano, Manabu Shirai, Yoshiaki Kubota, Yoshikazu Nakaoka
Förderung
- MEXT | Japan Society for the Promotion of Science (JSPS)
- MEXT | JST | Precursory Research for Embryonic Science and Technology (PRESTO)
Zitieren
APA
Ishibashi, T., Inagaki, T., Okazawa, M., Yamagishi, A., Ohta-Ogo, K., Asano, R., Masaki, T., Kotani, Y., Ding, X., Chikaishi-Kirino, T., Maedera, N., Shirai, M., Hatakeyama, K., Kubota, Y., Kishimoto, T., & Nakaoka, Y. (2024). IL-6/gp130 signaling in CD4 + T cells drives the pathogenesis of pulmonary hypertension. Proceedings of the National Academy of Sciences, 121(16). https://doi.org/10.1073/pnas.2315123121
Vancouver
Ishibashi T, Inagaki T, Okazawa M, Yamagishi A, Ohta-Ogo K, Asano R, et al. IL-6/gp130 signaling in CD4 + T cells drives the pathogenesis of pulmonary hypertension. Proceedings of the National Academy of Sciences. 2024;121(16). doi:10.1073/pnas.2315123121
BibTeX
@article{Ishibashi2024,
author = {Ishibashi, Tomohiko and Inagaki, Tadakatsu and Okazawa, Makoto and Yamagishi, Akiko and Ohta-Ogo, Keiko and Asano, Ryotaro and Masaki, Takeshi and Kotani, Yui and Ding, Xin and Chikaishi-Kirino, Tomomi and Maedera, Noriko and Shirai, Manabu and Hatakeyama, Kinta and Kubota, Yoshiaki and Kishimoto, Tadamitsu and Nakaoka, Yoshikazu},
title = {IL-6/gp130 signaling in CD4 + T cells drives the pathogenesis of pulmonary hypertension},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {16},
doi = {10.1073/pnas.2315123121}
}
EUVIMED